GANX

Gain Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.84

+0.21 (+12.88%)

Rating:C

Company Profile

CEO

Gene Mack

IPO Date

2021-03-19

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$1.64

Prev. Close

$1.63

Day Low

$1.63

Day High

$1.85

52W Low

$1.41

52W High

$4.34

Market Cap

$0.08B

Volume

0.68M

News SentimentBullish

Articles

Avg Positive

25.5%

Avg Negative

2.3%

Avg Neutral

72.5%

News Feed

Gain Therapeutics to Participate in Upcoming Virtual Investor Conferences in May

GlobeNewsWire·5/17/2021·↑ positive

Gain Therapeutics, Inc. Reports First Quarter 2021 Financial Results

GlobeNewsWire·5/10/2021·↑ positive

Gain Therapeutics Presents Positive In Vitro & In Vivo Data on Its Orally Bioavailable Brain Penetrant Star Compounds for the Treatment of GBA1 Parkinson's Disease & Related α-synucleopathies at the XXVI IAPRD World Congress